Cts Corp (CTS) · Oct 27, 2026 · Earnings

CTS earnings beat as margins surge and 2026 guidance rises

Beat — Adjusted EPS $0.77 vs ~$0.66 consensus; revenue $149.6M vs ~$146M

CTS earnings beat Q3 expectations, with 330-basis-point margin expansion and higher 2026 sales and adjusted EPS guidance.

CTS is a sensor, actuator and electronic-components maker trying to reduce its historical dependence on transportation by expanding industrial, medical, and aerospace & defense exposure. That diversification strategy was already underway, but this quarter shows it producing better growth and profitability: the company says diversified markets now represent 60% of sales, while the Millar acquisition adds medical and life-sciences sensing capabilities.

MetricQ3 2026Comparison / expectation
Revenue$149.6M$143.0M in Q3 2025; ~$146M consensus
Adjusted diluted EPS$0.77$0.60 in Q3 2025; ~$0.66 consensus
Adjusted gross margin42.2%38.9% in Q3 2025
Adjusted EBITDA margin24.7%23.8% in Q3 2025
Operating cash flow$43.5M$29.0M in Q3 2025
2026 revenue guidance$580M–$590MPreviously $565M–$585M
2026 adjusted EPS guidance$2.78–$2.88Previously $2.55–$2.70M

The quarter was a genuine beat, not just a favorable presentation. Revenue exceeded the published consensus of roughly $146 million, while adjusted EPS of $0.77 was above the roughly $0.66 expectation. The beat was supported by operating improvement: adjusted gross margin expanded 330 basis points and adjusted EBITDA margin rose 90 basis points. CTS states, “Sales were $149.6million in the third quarter of 2026, up 5% year-over-year.”

The growth mix is moving in the direction CTS needs. Diversified end-market revenue grew 7% year over year, versus 2% growth in transportation, and represented 60% of quarterly sales. Industrial demand was solid, aerospace and defense bookings were particularly strong, and medical revenue grew 21% year over year, although medical bookings were softer and aerospace revenue remained uneven. CTS says, “Diversified end-market sales grew 7% and now represent 60% of total sales.” 〔0〕

The outlook upgrade is the clearest change to the standing story. Management raised both revenue and adjusted EPS guidance, taking the midpoint of the EPS range from $2.625 to $2.83—about an 8% increase—and the revenue midpoint from $575 million to $585 million. The upgrade includes the expected Millar contribution, but the quarter’s margin and cash-flow performance also give it operational support. CTS says, “CTS is increasing its previous guidance of 2026 sales from a range of $565-$585million to $580-$590million and adjusted diluted EPS from a range of $2.55-$2.70to $2.78-$2.88.”

The quality of the earnings still needs to be read carefully, but it does not erase the beat. GAAP earnings benefited from a $12.5 million insurance recovery, while adjusted EPS included a sizable $12.7 million discrete tax adjustment; those items are excluded or separately adjusted in CTS’s non-GAAP presentation. The more durable evidence is the improvement in adjusted gross margin, bookings, and cash generation: operating cash flow rose to $43.5 million and nine-month free cash flow reached $82.3 million. CTS says, “Operating cash flow was $43.5million, up $14.5million from $29.0million in the third quarter of 2025.”

Bottom line: This materially advances CTS’s diversification story: the company beat a reasonable Q3 benchmark, expanded margins, and raised full-year targets. The main caveat is that part of reported profitability was distorted by tax and insurance items, but the underlying operating and cash-flow trend still landed clearly better than expected.

What to watch next

Q4 earnings report, early February 2027

Original filing on SEC EDGAR

More Cts Corp news

CTS earnings beat as margins surge and 2026 guidance rises | CTS Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.